|
IT1062206B
(it)
|
1974-02-01 |
1983-09-20 |
Rotta Research Lab S P A A S |
Derivati della tirosina attivi sulla muscolatura liscia
|
|
DE2423536A1
(de)
|
1974-05-15 |
1975-11-27 |
Bayer Ag |
3-amino-phenylessigsaeure-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als herbizide
|
|
US5424286A
(en)
|
1993-05-24 |
1995-06-13 |
Eng; John |
Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
|
|
US6174905B1
(en)
|
1996-09-30 |
2001-01-16 |
Mitsui Chemicals, Inc. |
Cell differentiation inducer
|
|
DE122007000044I2
(de)
|
1997-01-07 |
2011-05-05 |
Amylin Pharmaceuticals Inc |
Verwendung von exedinen und deren antagonisten zur verminderung der lebensmittelaufnahme
|
|
US6583139B1
(en)
|
1997-07-31 |
2003-06-24 |
Eugene D. Thorsett |
Compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
PL338457A1
(en)
|
1997-07-31 |
2000-11-06 |
Elan Pharm Inc |
Sulphonylated dipeptidic compounds capable to inhibit adhesion of leucocytes through the mediation of vla-4
|
|
EP1005445B1
(en)
|
1997-08-22 |
2004-05-26 |
F. Hoffmann-La Roche Ag |
N-alkanoylphenylalanine derivatives
|
|
US6191171B1
(en)
|
1997-11-20 |
2001-02-20 |
Merck & Co., Inc. |
Para-aminomethylaryl carboxamide derivatives
|
|
EP1992641A3
(en)
|
1998-12-07 |
2009-07-29 |
Ipsen Pharma |
GLP-1 analogues
|
|
US6902744B1
(en)
|
1999-01-14 |
2005-06-07 |
Amylin Pharmaceuticals, Inc. |
Exendin agonist formulations and methods of administration thereof
|
|
EP1150565A1
(en)
*
|
1999-02-08 |
2001-11-07 |
LION bioscience AG |
Thiazole derivatives and combinatorial libraries thereof
|
|
TWI302149B
(en)
|
1999-09-22 |
2008-10-21 |
Bristol Myers Squibb Co |
Substituted acid derivatives useful as antiodiabetic and antiobesity agents and method
|
|
TR200401217T4
(tr)
|
2000-03-07 |
2004-06-21 |
Aventis Pharma Deutschland Gmbh |
İkameli 3-Fenil-5-Alkoksi-1,3,4-Oksdiazol-2-one (ve) hormona duyarlı lipazın önlenmesinde kullanılması
|
|
WO2002028830A1
(en)
*
|
2000-09-29 |
2002-04-11 |
Ajinomoto Co.,Inc. |
Novel phenylalanine derivatives
|
|
WO2003048081A2
(en)
|
2001-12-04 |
2003-06-12 |
Bristol-Myers Squibb Company |
Glycinamides as factor xa inhibitors
|
|
EP1477482B1
(en)
|
2002-02-20 |
2010-04-14 |
Ajinomoto Co., Inc. |
Novel phenylalanine derivative
|
|
JPWO2003089410A1
(ja)
*
|
2002-04-19 |
2005-08-25 |
協和醗酵工業株式会社 |
フェニルアラニン誘導体
|
|
US20070276034A1
(en)
|
2002-05-31 |
2007-11-29 |
Luke Esposito |
Compounds, compositions and methods for the treatment of synucleinopathies
|
|
PL224879B1
(pl)
|
2002-09-04 |
2017-02-28 |
Pharmacopeia Drug Discovery Inc |
Pirazolo [1,5-a] pirymidynowy związek, jego zastosowanie do wytwarzania leku oraz zawierająca go farmaceutyczna kompozycja
|
|
MXPA05002571A
(es)
|
2002-09-04 |
2005-09-08 |
Schering Corp |
Pirazolopirimidinas como inhibidores de cinasa dependientes de ciclina.
|
|
US20040152750A1
(en)
|
2002-12-20 |
2004-08-05 |
Kodra Janos Tibor |
Novel glucagon antagonists
|
|
EP1644321B1
(en)
|
2003-06-13 |
2011-02-09 |
Laboratorios S.A.L.V.A.T., S.A. |
New benzamides as ppaty modulators
|
|
US7345049B2
(en)
|
2003-12-22 |
2008-03-18 |
Ajinomoto Co., Inc. |
Phenylalanine derivatives
|
|
CA2555594A1
(en)
*
|
2004-02-10 |
2005-08-25 |
Janssen Pharmaceutica N.V. |
Pyridazinones as antagonists of a4 integrins
|
|
WO2006117743A1
(en)
|
2005-05-03 |
2006-11-09 |
Ranbaxy Laboratories Limited |
Substituted aromatic compounds as antidiabetic agents
|
|
EP1899304A1
(en)
|
2005-05-23 |
2008-03-19 |
Arena Pharmaceuticals, Inc. |
5-amino-1h-pyrazole-3-carboxylic acid derivatives as agonists for the g-protein coupled receptor (gpcr) rup38 for the treatment of metabolic-related disorders thereof
|
|
US7825139B2
(en)
|
2005-05-25 |
2010-11-02 |
Forest Laboratories Holdings Limited (BM) |
Compounds and methods for selective inhibition of dipeptidyl peptidase-IV
|
|
EP1878730A1
(en)
|
2006-07-12 |
2008-01-16 |
Bayer Schering Pharma Aktiengesellschaft |
Substituted isoxazolines, pharmaceutical compositions containing the same, methods of preparing the same, and uses of the same
|
|
US7816324B2
(en)
|
2007-03-13 |
2010-10-19 |
Board Of Regents, The University Of Texas System |
Composition and method for the treatment of diseases affected by a peptide receptor
|
|
CA2688136A1
(en)
|
2007-06-08 |
2008-12-11 |
Advinus Therapeutics Private Limited |
Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application
|
|
WO2011094890A1
(en)
|
2010-02-02 |
2011-08-11 |
Argusina Inc. |
Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
|
|
JP2013530963A
(ja)
|
2010-06-09 |
2013-08-01 |
レセプトス インコーポレイテッド |
新規のｇｌｐ−１受容体安定化薬および調節薬
|
|
JP6007417B2
(ja)
|
2011-05-31 |
2016-10-12 |
レセプトス エルエルシー |
新規ｇｌｐ−１受容体安定剤および調節剤
|
|
BR112014013925B1
(pt)
|
2011-12-12 |
2022-02-22 |
Receptos Llc |
Compostos moduladores do receptor de glp-1 e composição e combinação farmacêutica compreendendo os ditos compostos
|
|
CN109867630A
(zh)
*
|
2013-06-11 |
2019-06-11 |
赛尔基因第二国际有限公司 |
新型glp-1受体调节剂
|
|
CA2955836C
(en)
|
2014-07-25 |
2023-02-14 |
Celgene International Ii Sarl |
Glp-1 receptor modulators
|